[en] This study reports the isolation, structural, biochemical, and functional characterization of a novel phosphodiesterase from Crotalus durissus collilineatus venom (CdcPDE). CdcPDE was successfully isolated from whole venom using three chromatographic steps and represented 0.7% of total protein content. CdcPDE was inhibited by EDTA and reducing agents, demonstrating that metal ions and disulfide bonds are necessary for its enzymatic activity. The highest enzymatic activity was observed at pH 8-8.5 and 37 °C. Kinetic parameters indicated a higher affinity for the substrate bis(p-nitrophenyl) phosphate compared to others snake venom PDEs. Its structural characterization was done by the determination of the protein primary sequence by Edman degradation and mass spectrometry, and completed by the building of molecular and docking-based models. Functional in vitro assays showed that CdcPDE is capable of inhibiting platelet aggregation induced by adenosine diphosphate in a dose-dependent manner and demonstrated that CdcPDE is cytotoxic to human keratinocytes. CdcPDE was recognized by the crotalid antivenom produced by the Instituto Butantan. These findings demonstrate that the study of snake venom toxins can reveal new molecules that may be relevant in cases of snakebite envenoming, and that can be used as molecular tools to study pathophysiological processes due to their specific biological activities.
Calvete, J.J., Rodríguez, Y., Quesada-Bernat, S., Pla, D., Toxin-resolved antivenomics-guided assessment of the immunorecognition landscape of antivenoms. Toxicon 148 (2018), 107–122, 10.1016/j.toxicon.2018.04.015.
Gutiérrez, J.M., Pereañez, J.A., The need for an integrated approach in confronting snakebite envenoming in latin america: the relevance of endogenous scientific and technoogical research. Vitae 23 (2016), 103–105, 10.17533/udea.vitae.v23n2a01.
Cruz, L.S., Vargas, R., Lopes, A.A., Snakebite envenomation and death in the developing world. Ethn Dis., 19, 2009 (S1-42–6).
World Health Organization, (eds.) Rabies and Envenomings: A Neglected Public Health Issue; Report of a Consultative Meeting, World Health Organization, Geneva, 10 January 2007, 2007, WHO, Geneva.
Ministério da Saúde, Acidentes por animais peçonhentos - Notificações registradas no Sistema de Informação de Agravos de Notificação - Brasil. http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sinannet/cnv/animaisbr.def, 2020. (Accessed 16 August 2020)
Costa, H.C., Bérnils, R.S., Répteis do Brasil e suas Unidades Federativas: Lista de espécies. Herpetologia Brasileira, 2018, 7.
Calvete, J.J., Venomics: integrative venom proteomics and beyond. Biochem. J. 474 (2017), 611–634, 10.1042/BCJ20160577.
Calvete, J.J., Juárez, P., Sanz, L., Snake venomics. Strategy and applications. J. Mass Spectrom. 42 (2007), 1405–1414, 10.1002/jms.1242.
Dhananjaya, B.L., Souza, C.J.M.D., An overview on nucleases (DNase, RNase, and phosphodiesterase) in snake venoms. Biochemistry Mosc. 75 (2010), 1–6, 10.1134/s0006297910010013.
Delezenne, C., Morel, H., Action catalytique des venins des serpents sur les acids nucleiques. CR Acad. Sci., 1919, 244–246.
Taborda, A.R., Taborda, L.C., Williams, J.N., Elvehjem, C.A., A study of the desoxyribonuclease activity of snake venoms. J. Biol. Chem. 195 (1952), 207–213.
Taborda, A.R., Taborda, L.C., Williams, J.N., Elvehjem, C.A., A study of the ribonuclease activity of snake venoms. J. Biol. Chem. 194 (1952), 227–233.
Uzawa, S., Über Die phosphomonoesterase und die phosphodiesterase. The Journal of Biochemistry 15 (1932), 19–28.
Dolapchiev, L.B., Vassileva, R.A., Koumanov, K.S., Venom exonuclease. II. Amino acid composition and carbohydrate, metal ion and lipid content in the Crotalus adamanteus venom exonuclease. Biochim. Biophys. Acta 622 (1980), 331–336, 10.1016/0005-2795(80)90044-6.
Kini, R.M., Gowda, T.V., Rapid method for separation and purification of four isoenzymes of phosphodiesterase from Trimeresurus flavoviridis (habu snake) venom. J. Chromatogr. A 291 (1984), 299–305, 10.1016/S0021-9673(00)95032-5.
Al-Saleh, S.S.M., Khan, S., Purification and characterization of phosphodiesterase I from Walterinnesia aegyptia venom. Prep. Biochem. Biotechnol. 41 (2011), 262–277, 10.1080/10826068.2011.575319.
Perron, S., Mackessy, S.P., Hyslop, R.M., Purification and characterization of exonuclease from rattlesnake venom. J. Colo.-Wyo. Acad. Sci 25 (1993), 21–22.
Fox, J.W., A brief review of the scientific history of several lesser-known snake venom proteins: l-amino acid oxidases, hyaluronidases and phosphodiesterases. Toxicon 62 (2013), 75–82, 10.1016/j.toxicon.2012.09.009.
Mori, N., Nikai, T., Sugihara, H., Phosphodiesterase from the venom of Crotalus ruber ruber. Int. J. Biochem 19 (1987), 115–119, 10.1016/0020-711x(87)90321-1.
Valério, A.A., Corradini, A.C., Panunto, P.C., Mello, S.M., Hyslop, S., Purification and characterization of a phosphodiesterase from Bothrops alternatus snake venom. J. Protein Chem. 21 (2002), 495–503, 10.1023/a:1022414503995.
Trummal, K., Aaspõllu, A., Tõnismägi, K., Samel, M., Subbi, J., Siigur, J., Siigur, E., Phosphodiesterase from Vipera lebetina venom - structure and characterization. Biochimie 106 (2014), 48–55, 10.1016/j.biochi.2014.07.020.
Segovia, M., Figueroa, F.L., Detection of a 3′, 5′-cyclic-AMP phosphodiesterase activity in the lichenized fungus Evernia prunastri. Plant Biosystems - An International Journal Dealing with All Aspects of Plant Biology 141 (2007), 123–127, 10.1080/11263500601153610.
Jeon, Y.H., Heo, Y.-S., Kim, C.M., Hyun, Y.-L., Lee, T.G., Ro, S., Cho, J.M., Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development. Cell. Mol. Life Sci. 62 (2005), 1198–1220, 10.1007/s00018-005-4533-5.
Peng, L., Xu, X., Shen, D., Zhang, Y., Song, J., Yan, X., Guo, M., Purification and partial characterization of a novel phosphodiesterase from the venom of Trimeresurus stejnegeri: inhibition of platelet aggregation. Biochimie 93 (2011), 1601–1609, 10.1016/j.biochi.2011.05.027.
Pérez-Torres, S., Cortés, R., Tolnay, M., Probst, A., Palacios, J.M., Mengod, G., Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp. Neurol. 182 (2003), 322–334, 10.1016/s0014-4886(03)00042-6.
Castro, A., Jerez, M.J., Gil, C., Martinez, A., Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors. Med. Res. Rev. 25 (2005), 229–244, 10.1002/med.20020.
Miller, C.L., Yan, C., Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications. J. Cardiovasc. Transl. Res. 3 (2010), 507–515, 10.1007/s12265-010-9203-9.
Uckert, S., Hedlund, P., Andersson, K.-E., Truss, M.C., Jonas, U., Stief, C.G., Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur. Urol. 50 (2006), 1194–1207 discussion 1207 https://doi.org/10.1016/j.eururo.2006.05.025.
Mehats, C., Andersen, C.B., Filopanti, M., Jin, S.-L.C., Conti, M., Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends in Endocrinology & Metabolism 13 (2002), 29–35, 10.1016/S1043-2760(01)00523-9.
Massimi, M., Cardarelli, S., Galli, F., Giardi, M.F., Ragusa, F., Panera, N., Cinque, B., Cifone, M.G., Biagioni, S., Giorgi, M., Increase of intracellular cyclic AMP by PDE4 inhibitors affects HepG2 cell cycle progression and survival. J. Cell. Biochem. 118 (2017), 1401–1411, 10.1002/jcb.25798.
de Oliveira, I.S., Cardoso, I.A., Bordon, K. de C.F., Carone, S.E.I., Boldrini-França, J., Pucca, M.B., Zoccal, K.F., Faccioli, L.H., Sampaio, S.V., Rosa, J.C., Arantes, E.C., Global proteomic and functional analysis of Crotalus durissus collilineatus individual venom variation and its impact on envenoming. J. Proteomics 191 (2019), 153–165, 10.1016/j.jprot.2018.02.020.
Amorim, F.G., Morandi-Filho, R., Fujimura, P.T., Ueira-Vieira, C., Sampaio, S.V., New findings from the first transcriptome of the Bothrops moojeni snake venom gland. Toxicon 140 (2017), 105–117, 10.1016/j.toxicon.2017.10.025.
Tang, E.L.H., Tan, C.H., Fung, S.Y., Tan, N.H., Venomics of Calloselasma rhodostoma, the Malayan pit viper: a complex toxin arsenal unraveled. J. Proteomics 148 (2016), 44–56, 10.1016/j.jprot.2016.07.006.
Yang, Z.-M., Yang, Y.-E., Chen, Y., Cao, J., Zhang, C., Liu, L.-L., Wang, Z.-Z., Wang, X.-M., Wang, Y.-M., Tsai, I.-H., Transcriptome and proteome of the highly neurotoxic venom of Gloydius intermedius. Toxicon. 107 (2015), 175–186, 10.1016/j.toxicon.2015.08.010.
Amorim, F.G., Costa, T.R., Baiwir, D., De Pauw, E., Quinton, L., Sampaio, S.V., Proteopeptidomic, functional and immunoreactivity characterization of Bothrops moojeni snake venom: influence of snake gender on venom composition. Toxins (Basel), 10, 2018, 10.3390/toxins10050177.
Boldrini-França, J., Cologna, C.T., Pucca, M.B., Bordon, K. de C.F., Amorim, F.G., Anjolette, F.A.P., Cordeiro, F.A., Wiezel, G.A., Cerni, F.A., Pinheiro-Junior, E.L., Shibao, P.Y.T., Ferreira, I.G., de Oliveira, I.S., Cardoso, I.A., Arantes, E.C., Minor snake venom proteins: structure, function and potential applications. Biochim. Biophys. Acta Gen. Subj. 1861 (2017), 824–838, 10.1016/j.bbagen.2016.12.022.
Aird, S.D., Ophidian envenomation strategies and the role of purines. Toxicon 40 (2002), 335–393, 10.1016/s0041-0101(01)00232-x.
Santoro, M.L., Vaquero, T.S., Paes Leme, A.F., Serrano, S.M.T., NPP-BJ, a nucleotide pyrophosphatase/phosphodiesterase from Bothrops jararaca snake venom, inhibits platelet aggregation. Toxicon 54 (2009), 499–512, 10.1016/j.toxicon.2009.05.016.
Mitra, J., Bhattacharyya, D., Phosphodiesterase from Daboia russelli russelli venom: purification, partial characterization and inhibition of platelet aggregation. Toxicon 88 (2014), 1–10, 10.1016/j.toxicon.2014.06.004.
Björk, W., Purification of phosphodiesterase from Bothrops atrox venom, with special consideration of the elimination of monophosphatases. J. Biol. Chem. 238 (1963), 2487–2490.
Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970), 680–685, 10.1038/227680a0.
Edman, P., Begg, G., A protein sequenator. Eur. J. Biochem. 1 (1967), 80–91, 10.1111/j.1432-1033.1967.tb00047.x.
Altschul, S.F., Madden, T.L., Schäffer, A.A., Zhang, J., Zhang, Z., Miller, W., Lipman, D.J., Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25 (1997), 3389–3402, 10.1093/nar/25.17.3389.
Morsa, D., Baiwir, D., La Rocca, R., Zimmerman, T.A., Hanozin, E., Grifnée, E., Longuespée, R., Meuwis, M.-A., Smargiasso, N., Pauw, E.D., Mazzucchelli, G., Multi-enzymatic limited digestion: the next-generation sequencing for proteomics?. J. Proteome Res. 18 (2019), 2501–2513, 10.1021/acs.jproteome.9b00044.
The UniProt Consortium, UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res., 47, 2019, 10.1093/nar/gky1049 D506–D515.
Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F.T., de Beer, T.A.P., Rempfer, C., Bordoli, L., Lepore, R., Schwede, T., SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46 (2018), W296–W303, 10.1093/nar/gky427.
Grosdidier, A., Zoete, V., Michielin, O., SwissDock, a protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 39 (2011), W270–W277, 10.1093/nar/gkr366.
Grosdidier, A., Zoete, V., Michielin, O., Fast docking using the CHARMM force field with EADock DSS. J. Comput. Chem. 32 (2011), 2149–2159, 10.1002/jcc.21797.
Laskowski, RomanA., Rullmann, J.AntoonC., MacArthur, MalcolmW., Kaptein, R., Thornton, JanetM., AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR, 8, 1996, 10.1007/BF00228148.
Laskowski, R.A., MacArthur, M.W., Moss, D.S., Thornton, J.M., PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26 (1993), 283–291, 10.1107/S0021889892009944.
Colovos, C., Yeates, T.O., Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci. 2 (1993), 1511–1519, 10.1002/pro.5560020916.
Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., Ferrin, T.E., UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25 (2004), 1605–1612, 10.1002/jcc.20084.
Niesen, F.H., Berglund, H., Vedadi, M., The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability. Nat. Protoc. 2 (2007), 2212–2221, 10.1038/nprot.2007.321.
Saha, S., Raghava, G.P.S., Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins 65 (2006), 40–48, 10.1002/prot.21078.
Medeiros, J.M., Oliveira, I.S., Ferreira, I.G., Alexandre-Silva, G.M., Cerni, F.A., Zottich, U., B. Pucca, M., Fatal rattlesnake envenomation in northernmost Brazilian Amazon: a case report and literature overview. Reports, 3, 2020, 9, 10.3390/reports3020009.
da Silva, M.H., Bier, O.G., Titration of antiserum to South American rattlesnake (Crotalus durissus terrificus) venom by inhibition of phospholipase A2 activity. Toxicon 20 (1982), 563–569, 10.1016/0041-0101(82)90050-2.
Philipps, G.R., Purification and characterization of phosphodiesterase from Crotalus venom. Hoppe-Seyler's Z. Physiol. Chem. 356 (1975), 1085–1096, 10.1515/bchm2.1975.356.2.1085.
Sugihara, H., Nikai, T., Naruse, M., Kishida, M., Mori, N., Purification and characterization of phosphodiesterase from the venom of Trimeresurus mucrosquamatus. Int. J. Biochem 18 (1986), 203–207, 10.1016/0020-711x(86)90106-0.
Al-Saleh, S.S.M., Khan, S.U., Ashraf, M., Biochemical characterization and some biological properties of the phosphodiesterase I purified from Agistrodon bilineatus venom. Indian J. Biochem. Biophys. 46 (2009), 221–229.
Ullah, A., Ullah, K., Ali, H., Betzel, C., ur Rehman, S., The sequence and a three-dimensional structural analysis reveal substrate specificity among snake venom phosphodiesterases. Toxins, 11, 2019, 625, 10.3390/toxins11110625.
Halim, H.Y., Shaban, E.A., Hagag, M.M., Daoud, E.W., el-Asmar, M.F., Purification and characterization of phosphodiesterase (exonuclease) from Cerastes cerastes (Egyptian sand viper) venom. Toxicon 25 (1987), 1199–1207, 10.1016/0041-0101(87)90138-3.
Moremen, K.W., Tiemeyer, M., Nairn, A.V., Vertebrate protein glycosylation: diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 13 (2012), 448–462, 10.1038/nrm3383.
Stowell, S.R., Ju, T., Cummings, R.D., Protein glycosylation in cancer. Annu. Rev. Pathol. 10 (2015), 473–510, 10.1146/annurev-pathol-012414-040438.
Doley, R., Kini, R.M., Protein complexes in snake venom. Cell. Mol. Life Sci. 66 (2009), 2851–2871, 10.1007/s00018-009-0050-2.
Casewell, N.R., Wagstaff, S.C., Wüster, W., Cook, D.A.N., Bolton, F.M.S., King, S.I., Pla, D., Sanz, L., Calvete, J.J., Harrison, R.A., Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 9205–9210, 10.1073/pnas.1405484111.
Andrade-Silva, D., Zelanis, A., Kitano, E.S., Junqueira-de-Azevedo, I.L.M., Reis, M.S., Lopes, A.S., Serrano, S.M.T., Proteomic and glycoproteomic profilings reveal that post-translational modifications of toxins contribute to venom phenotype in snakes. J. Proteome Res. 15 (2016), 2658–2675, 10.1021/acs.jproteome.6b00217.
Zancolli, G., Sanz, L., Calvete, J.J., Wüster, W., Venom On-a-Chip: a fast and efficient method for comparative venomics. Toxins (Basel), 9, 2017, 10.3390/toxins9060179.
Levy, Z., Bdolah, A., Multiple molecular forms of snake venom phosphodiesterase from Vipera palastinae. Toxicon 14 (1976), 389–390, 10.1016/0041-0101(76)90086-6.
Philipps, G.R., Purification and characterization of phosphodiesterase I from Bothrops atrox. Biochim. Biophys. Acta 432 (1976), 237–244, 10.1016/0005-2787(76)90165-9.
Ibrahim, N.M., Salama, W.H., Hakim, A.E.E., Phosphodiesitrase activity of some Egyptian snake venoms: biochemical and immunological characteristics and effect on blood coagulation of phosphodiesterase enzyme from Naja nigricollis venom. J. Chem. Pharm. Res., 8, 2016, 11.
Zalatan, J.G., Fenn, T.D., Brunger, A.T., Herschlag, D., Structural and functional comparisons of nucleotide pyrophosphatase/phosphodiesterase and alkaline phosphatase: implications for mechanism and evolution. Biochemistry 45 (2006), 9788–9803, 10.1021/bi060847t.
Laustsen, A.H., María Gutiérrez, J., Knudsen, C., Johansen, K.H., Bermúdez-Méndez, E., Cerni, F.A., Jürgensen, J.A., Ledsgaard, L., Martos-Esteban, A., Øhlenschlæger, M., Pus, U., Andersen, M.R., Lomonte, B., Engmark, M., Pucca, M.B., Pros and cons of different therapeutic antibody formats for recombinant antivenom development. Toxicon 146 (2018), 151–175, 10.1016/j.toxicon.2018.03.004.
Bremel, R.D., Homan, E.J., An integrated approach to epitope analysis I: dimensional reduction, visualization and prediction of MHC binding using amino acid principal components and regression approaches. Immunome Res, 6, 2010, 7, 10.1186/1745-7580-6-7.
Sivalingam, G.N., Shepherd, A.J., An analysis of B-cell epitope discontinuity. Mol. Immunol. 51 (2012), 304–309, 10.1016/j.molimm.2012.03.030.
Oyama, E., Furudate, N., Senuki, K., Takahashi, H., Purification and characterization of a new platelet aggregation inhibitor with dissociative effect on ADP-induced platelet aggregation, from the venom of Protobothrops elegans (Sakishima-habu). Toxicon 53 (2009), 706–712, 10.1016/j.toxicon.2009.02.016.
King, G.F., Venoms as a platform for human drugs: translating toxins into therapeutics. Expert. Opin. Biol. Ther. 11 (2011), 1469–1484, 10.1517/14712598.2011.621940.
Bordon, K. de C.F., Cologna, C.T., Fornari-Baldo, E.C., Pinheiro-Júnior, E.L., Cerni, F.A., Amorim, F.G., Anjolette, F.A.P., Cordeiro, F.A., Wiezel, G.A., Cardoso, I.A., Ferreira, I.G., de Oliveira, I.S., Boldrini-França, J., Pucca, M.B., Baldo, M.A., Arantes, E.C., From animal poisons and venoms to medicines: achievements, challenges and perspectives in drug discovery. Front. Pharmacol., 11, 2020, 1132, 10.3389/fphar.2020.01132.
Gasanov, S.E., Alsarraj, M.A., Gasanov, N.E., Rael, E.D., Cobra venom cytotoxin free of phospholipase A2 and its effect on model membranes and T leukemia cells. J. Membr. Biol. 155 (1997), 133–142, 10.1007/s002329900165.
de Oliveira, I.S., Manzini, R.V., Ferreira, I.G., Cardoso, I.A., Bordon, K. de C.F., Machado, A.R.T., Antunes, L.M.G., Rosa, J.C., Arantes, E.C., Cell migration inhibition activity of a non-RGD disintegrin from Crotalus durissus collilineatus venom. J Venom Anim Toxins Incl Trop Dis, 24, 2018, 28, 10.1186/s40409-018-0167-6.
Maria, D.A., Vassão, R.C., Ruiz, I.R.G., Haematopoietic effects induced in mice by the snake venom toxin jararhagin. Toxicon 42 (2003), 579–585, 10.1016/S0041-0101(03)00237-X.
Pucca, M.B., Peigneur, S., Cologna, C.T., Cerni, F.A., Zoccal, K.F., Bordon, K. de C.F., Faccioli, L.H., Tytgat, J., Arantes, E.C., Electrophysiological characterization of the first Tityus serrulatus alpha-like toxin, Ts5: evidence of a pro-inflammatory toxin on macrophages. Biochimie 115 (2015), 8–16, 10.1016/j.biochi.2015.04.010.
Pucca, M.B., Ahmadi, S., Cerni, F.A., Ledsgaard, L., Sørensen, C.V., McGeoghan, F.T.S., Stewart, T., Schoof, E., Lomonte, B., Keller, U. auf dem, Arantes, E.C., Çalışkan, F., Laustsen, A.H., Unity makes strength: exploring intraspecies and interspecies toxin synergism between phospholipases A2 and cytotoxins. Front. Pharmacol., 11, 2020, 611, 10.3389/fphar.2020.00611.
Ahmadi, S., Pucca, M.B., Jürgensen, J.A., Janke, R., Ledsgaard, L., Schoof, E.M., Sørensen, C.V., Çalışkan, F., Laustsen, A.H., An in vitro methodology for discovering broadly-neutralizing monoclonal antibodies. Sci. Rep., 10, 2020, 10765, 10.1038/s41598-020-67654-7.
Rivel, M., Solano, D., Herrera, M., Vargas, M., Villalta, M., Segura, Á., Arias, A.S., León, G., Gutiérrez, J.M., Pathogenesis of dermonecrosis induced by venom of the spitting cobra, Naja nigricollis: an experimental study in mice. Toxicon 119 (2016), 171–179, 10.1016/j.toxicon.2016.06.006.
Sant'Ana Malaque, C.M., Gutiérrez, J.M., Snakebite envenomation in Central and South America. Brent, J., Burkhart, K., Dargan, P., Hatten, B., Megarbane, B., Palmer, R., (eds.) Critical Care Toxicology, 2015, Springer International Publishing, Cham, 1–22.
